"As for what happens if topline is positive----These are the messages I dread on a website in a stock I am invested in. If these are the majority of posts, that stock is doomed. Thank goodness such comments are a minority of posts here. No offense, I would rather we stick to debating scientific or business aspects rather than daydreaming but thats just me."

That's an "interesting" comment Fenix, seeing as this is an investment bulletin board and most, if not all, of us are here to make some $. Even the most superficial due diligence on Resverlogix should include a forecast of potential increase in share price and market cap, in my opinion, especially with a top-line outcome that is arguably binary. We are a full month past the April 18th guidance that trial wrap up, including top-line data, should be expected in the next 2-4 months. The bookends are closing in. With a current market cap below $1 billion and projected market cap several fold higher with successful BETonMACE trial, it is perfectly reasonable to "daydream". From an investor perspective, the scientific, business and profit potential are all inter-related. And with top-line data projected to arrive in 1 to 3 months (current guidance), it is a good idea to have put some advanced thought into entry and exit points in case certain milestones are met or missed. 

BearDownAZ